In a new report by Quartz Advisor, data shows that since 2016, traffic fatalities fell in four states that legalized adult-use cannabis, with a slight increase of fatalities in five states that have not legalized cannabis. The report showed some anomalies, however, and there was a slight increase of... Read more
Friday, Oct. 27 was a historic day for cannabis in Georgia and throughout the country, as it was the first day that pharmacists were legally allowed to sell cannabis at the pharmacy counter. Dr. Ankit Patel was the first pharmacist to begin selling cannabis at his pharmacy, Robins Pharmacy.... Read more
Meta Platforms Inc., aka Mark Zuckerberg’s tech giant behind social media giants like Facebook and Instagram, has chosen to ignore advice from its ethics watchdog regarding how the platform manages posts connected to psychedelics. The drama dates back to a 2022 “paid partner” post that promoted a ketamine treatment... Read more
A major supplier of drug testing kits has announced an updated screening panel which no longer tests for cannabis and prioritizes testing for fentanyl.  Psychemedics, a Massachusetts-based producer of drug testing kits announced Friday that they would be launching a new five-panel drug screen which will “ the spotlight... Read more
Top Marijuana Stocks For Cannabis Investing 2024

3 Marijuana Stocks Cannabis Investors Should Keep On Their Radar 2024

The post Top Marijuana Stocks For Cannabis Investing 2024 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Read more
3 Marijuana Stocks To Buy Last Week Of October
Marijuana Stocks To Buy And Add To Your 2024 Watchlist
For the first time, a psilocybin mushroom license was granted in New Zealand, marking a major milestone in a Māori health science. The effort was led by Rangiwaho marae, based south of Gisborne in New Zealand.  According to an Oct. 26 joint media release, Rua Bioscience, a biopharmaceutical business... Read more
Switzerland will allow Europe’s first non-medical cannabis dispensaries to open and operate as part of a study to examine how controlled access to legal cannabis may affect health and consumption patterns of regular cannabis consumers. An announcement was made Friday about “Grashaus Projects” by German CBD and cannabinoid research... Read more
A survey, released this week by the cannabis wellness company EO Care, found that “18 percent of respondents have used cannabis for health reasons in the past year, 19 percent have used cannabis for recreational reasons, and 14 percent have used it for both.” It also revealed that the... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )